CP-724714

Alias: CP 724714; CP-724714; CP724714
Cat No.:V0557 Purity: ≥98%
CP-724714 (CP724714) is an orally bioavailable,potent, selective inhibitor of HER2/ErbB2 with potential anticancer activity.
CP-724714 Chemical Structure CAS No.: 537705-08-1
Product category: EGFR
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
2mg
5mg
10mg
25mg
50mg
100mg
250mg
Other Sizes

Other Forms of CP-724714:

  • CP-724714
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

CP-724714 (CP724714) is an orally bioavailable, potent, selective inhibitor of HER2/ErbB2 with potential anticancer activity. Its IC50 value for HER2/ErbB2 inhibition is 10 nM. In cell-free experiments, CP 724714 exhibits >640-fold selectivity for blocking HER2/ErbB2 over EGFR, InsR, IRG-1R, PDGFR, VEGFR2, Abl, Src, c-Met, etc.

Biological Activity I Assay Protocols (From Reference)
Targets
HER2/ErbB2 (IC50 = 10 nM)
ln Vitro
CP-724,714 exhibits a 6.4 μM IC50 and is specifically marked against EGFR. For IR, IGF-1R, PDGFRβ, VGFR2, abl. Src, c-Met c-jun NH2-terminal kinase (JNK)-2, JNK-3, ZAP-70, cyclin-dependent kinase (CDK)-2, and CDK-5, CP-724,714 is >1,000 times less potent. With an IC50 of 32 nM, CP-724,714 potently inhibits the EGF-induced autophosphorylation of the erbB2 kinase domain chimera, but it is noticeably less effective against EGFR in transfected NIH3T3 cells. With an IC50 of 0.25 and 0.95 μM, CP-724,714 selectively suppresses the growth of erbB2-amplified cells, such as BT-474 and SKBR3. At 1 μM, CP-724,714 causes BT-474 cells to accumulate in the G1 phase and significantly decrease in the S-phase. (Source: ) It is probable that CP-724,714 causes hepatotoxicity through a combination of hepatocellular damage and hepatobiliary cholestatic mechanisms. Cholyl-lysyl fluorescein and taurocholate (TC) efflux into canaliculi in cryopreserved and fresh cultured human hepatocytes, respectively, are both inhibited by CP-724,714. With an IC50 of 16 μM, CP-724,714 inhibits TC transport in membrane vesicles expressing the human bile salt export pump. Additionally, with an IC50 of ~28 μM, it inhibits MDR1, the main efflux transporter in bile canaliculi.[2]
ln Vivo
CP-724,714 (25 mg/kg) is rapidly absorbed following intraperitoneal injection and, in FRE-erbB2 or BT-474 xenografts, results in a decrease in tumor erbB2 receptor phosphorylation following dosage. In mice bearing FRE-erbB2 xenografts (s.c.), CP-724,714 causes apoptosis and, at 50 mg/kg, exhibits 50% inhibition of tumor growth without causing weight loss or death. Additionally, in MDA-MB-453, MDA-MB-231, LoVo (colon), and Colo-205 (colon) xenografts, CP-724,714 exhibits strong antitumor activity. Moreover, in BT-474 xenografts, CP-724,714 (30 or 100 mg/kg) lowers Akt phosphorylation and extracellular signal-regulated kinase.[1]
Enzyme Assay
Baculovirus-infected Sf9 cells express recombinant erbB2 (amino acid residues 675–1255) and EGFR (amino acid residues 668–1211) intracellular domains as glutathione S-transferase fusion proteins. To be used in the assay, the proteins are purified using affinity chromatography on glutathione Sepharose beads. Not at all MaxiSorp 96-well plates are coated by incubating 100 μL/well of 0.25 mg/mL poly(Glu:Tyr, 4:1), PGT in PBS for an entire night at 37 °C. After aspirating out any excess PGT, the plate is three times cleaned with wash buffer (0.1% Tween 20 in PBS). The kinase reaction takes place in 50 μL of 50 mm HEPES (pH 7.4), which also contains approximately 15 ng of recombinant protein, 125 mm sodium chloride, 10 mm magnesium chloride, 0.1 mm sodium orthovanadate, 1 mm ATP, and magnesium chloride. The final concentration of DMSO is 2.5% after inhibitors are added. When ATP is added, phosphorylation begins and continues for six minutes at room temperature while being constantly shaken. Aspiration of the reaction mixture and four washes with wash buffer are used to stop the kinase reaction. Following a 25-minute incubation with 50 μL/well HRP conjugated-PY54 antiphosphotyrosine antibody, diluted to 0.2 μg/mL in blocking buffer (3% BSA, 0.05% Tween 20 in PBS), phosphorylated PGT level is determined. By aspirating out the antibody, the plate is cleaned four times using wash buffer. Tentamethylbenzidine Microwell Peroxidase Substrate, 50 μL/well, is added to develop the colorimetric signal.50 μL/well of sulfuric acid, 0.09 m, is added to stop the signal. By measuring the absorbance at 450 nm, the phosphotyrosine product formed is estimated. In wells lacking ATP, kinase protein, or PGT, the signal for controls is usually A0.6–1.2, is proportional to the incubation period of 6 minutes, and has almost no background.
Cell Assay
In 24-well plates, cells are seeded in duplicate, with 5~10 × 103 per well. The following day, CP-724,714 is added by titrating at least six dilutions, ranging from 0.1 nM to 10 μM. Additionally, control wells devoid of CP-724,714 are seeded. After six to seven days of growth, the number of surviving cells is determined. Cells are trypsinized, then immediately counted using a Coulter Z2 particle counter and put in isotone solution. For every concentration, the calculation of growth inhibition is expressed as [(1− experimental value / control value) × 100]. Dose-response curves are averaged after being repeated at least twice. Calcusyn software is used to calculate IC50 values.
Animal Protocol
FRE-erbB2 BT-474, MDA-MB-453, MDA-MB-231, LoVo (colon), and Colo-205 (colon) xenografts are established in athymic female mice (CD-1 nu/nu).
~100 mg/kg.
Administered via p.o.
References

[1]. Cancer Res . 2007 Oct 15;67(20):9887-93.

[2]. 2009 Apr;108(2):492-500.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C27H27N5O3
Molecular Weight
469.53
CAS #
537705-08-1
SMILES
O=C(NC/C=C/C1=CC2=C(NC3=CC=C(OC4=CC=C(C)N=C4)C(C)=C3)N=CN=C2C=C1)COC
InChi Key
LLVZBTWPGQVVLW-SNAWJCMRSA-N
InChi Code
InChI=1S/C27H27N5O3/c1-18-13-21(8-11-25(18)35-22-9-6-19(2)29-15-22)32-27-23-14-20(7-10-24(23)30-17-31-27)5-4-12-28-26(33)16-34-3/h4-11,13-15,17H,12,16H2,1-3H3,(H,28,33)(H,30,31,32)/b5-4+
Chemical Name
(E)-2-methoxy-N-(3-(4-(3-methyl-4-(6-methylpyridin-3-yloxy)phenylamino)quinazolin-6-yl)allyl)acetamide.
Synonyms
CP 724714; CP-724714; CP724714
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: ~94 mg/mL (~200.2 mM)
Water: <1 mg/mL
Ethanol: ~94 mg/mL (~200.2 mM)
Solubility (In Vivo)
0.5% methylcellulose: 30mg/mL
 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.1298 mL 10.6489 mL 21.2979 mL
5 mM 0.4260 mL 2.1298 mL 4.2596 mL
10 mM 0.2130 mL 1.0649 mL 2.1298 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT00055926 Completed Drug: CP-724,714 Breast Cancer Jonsson Comprehensive Cancer Center January 2003 Phase 1
NCT00102895 Terminated Drug: CP-724,714 Breast Neoplasms
Neoplasm Metastasis
Pfizer April 2005 Phase 2
Biological Data
  • CP-724714

    A, selective inhibition of erbB2 kinase by CP-724,714.

  • CP-724714

    Effect of CP-724,714 on the growth of tumor xenografts. Cancer Res. 2007 Oct 15;67(20):9887-93.

  • CP-724714

    Effect of CP-724,714 on phospho-Erk and phospho-Akt in BT-474 xenografts. Cancer Res. 2007 Oct 15;67(20):9887-93.

Contact Us